Breaks Categories: News

ThursdayJun 06, 2019 9:24 am

NetworkNewsBreaks – Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Begins Phase Two Drilling at Cyclops Nickel-Cobalt Project; Completes Debt Settlement

Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE), a Canada-based exploration company, this morning announced the beginning of phase two drilling at its flagship Cyclops nickel-cobalt development project in Indonesia. The drilling is part of a complex exploration program intended to verify historical results and produce a resource estimate in late 2019. In addition to historically identified and drill-tested areas, Pacific Rim Cobalt’s efforts will also focus on previously undrilled prospects. The company’s goal for the second half of 2019 is to complete up to 50 additional drill holes and then establish a maiden compliant resource on the project.…

Continue Reading

WednesdayJun 05, 2019 10:41 am

NetworkNewsBreaks – Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) Renews Access Agreements for Port and Power

Canadian iron ore exploration and development company Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) this morning announced the renewal of its letter of intent (“LOI”) with TransInvestServis (“TIS”) for storage and cape-size ship loading capacity at TIS’ privately owned berth at Port Yuzhny in an effort to match projected production from the phased build of Black Iron’s Shymanivske Project. In addition, the company has renewed its LOI with DTEK DNIPRO GRIDS JSC to secure the required electricity to operate the mine and processing plant. “Renewal of our major infrastructure LOIs is important to provide confidence for investors in…

Continue Reading

WednesdayJun 05, 2019 10:04 am

NetworkNewsBreaks – Golden Developing Solutions Inc. (DVLP) Announces Official Move-In Date for Denver Production Facility

Emerging leader in the cannabis, hemp and cannabidiol (CBD) marketplace Golden Developing Solutions Inc. (OTC: DVLP) this morning announced June 10, 2019, as the official date that the company will move into its new 25,000-square-foot production facility in Denver, Colorado. According to the update, a new financing agreement is funding equipment to outfit the facility, and the company anticipates a five-fold increase in total production levels in the first three months following delivery and installation. “We are excited to get into the new facility, get organized, and ramp up operations,” DVLP CEO Stavros Triant stated in the news release. “This…

Continue Reading

WednesdayJun 05, 2019 9:53 am

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Launches QuadSight Demonstration Center

Automotive technology innovator Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) this morning announced the opening of its innovative demonstration center. Per the update, the QuadSight demonstration center, located near the company's offices, provides investors, customers and business partners with the opportunity to ride in a vehicle that’s equipped with Foresight’s automotive vision system. The advanced demonstration equipment simulates rain, fog, glare and complete darkness, enabling participants to see and experience, in real time, QuadSight’s obstacle detection capabilities in extreme weather and lighting conditions. “We are proud to launch our innovative demonstration center in Israel to investors and partners,” Foresight…

Continue Reading

WednesdayJun 05, 2019 9:28 am

NetworkNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) to Showcase Alzheimer’s Drug Candidate XPro1595 at TNF Conference

INmune Bio Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, on Tuesday announced that its director of neuroscience, CJ Barnum, Ph.D., will be giving a scientific talk and presenting a poster on Alzheimer’s drug candidate XPro1595 at the TNF Conference on June 4, 2019. According to the update, “A Phase 1b biomarker-directed study to target soluble tumor necrosis factor in Alzheimer’s (“AD”) patients,” is the title of the poster and talk in which Barnum will discuss INmune Bio’s clinical approach to treating Alzheimer’s disease. “XPro1595 has been represented…

Continue Reading

TuesdayJun 04, 2019 1:47 pm

NetworkNewsBreaks – InterDigital, Inc. (NASDAQ: IDCC) Closes $400M Senior Convertible Notes Offering

InterDigital (NASDAQ: IDCC) has closed a $400 million offering of 2.00% Senior Convertible Notes. Per the update, the notes are due in 2024 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The offering of $400 million includes $50 million in aggregate principal amount of the notes issued per the full exercise of the over-allotment option. The notes will be senior unsecured obligations of InterDigital and will pay interest, at a rate of 2.00% per year, semi-annually in cash on June 1 and December 1, and will mature on June 1, 2024. ROTH…

Continue Reading

TuesdayJun 04, 2019 1:40 pm

NetworkNewsBreaks – Prescient Therapeutics Ltd. (ASX: PTX) Completes $7 Million AUD PIPE

Clinical stage oncology company Prescient Therapeutics Limited (ASX: PTX) has completed a $7 Million AUD PIPE with institutional and sophisticated investors. According to the update, the placement involved the issue of approximately 140 million shares, each at $0.05, largely to institutional investors. ROTH Capital Partners acted as U.S. placement agent for the transaction. “Prescient is delighted with the support from its existing shareholders, and is very pleased to welcome new shareholders to the Company, including new US and Australian institutional investors with particular expertise in life science investing,” PTX CEO Steven Yatomi-Clarke said in the news release. “It is encouraging…

Continue Reading

TuesdayJun 04, 2019 1:00 pm

NetworkNewsBreaks – The Lovesac Company (NASDAQ: LOVE) Secures $103.5M Through Underwritten Public Offering

The Lovesac Company (NASDAQ: LOVE) has completed an underwritten public offering of 2,875,000 shares of its common stock. According to the update, the offering resulted in gross proceeds of approximately $103.5 million, which Lovesac intends to use for increased sales and marketing expenses, product development, working capital and other general corporate purposes. The offering consisted of 750,000 Lovesac-offered shares and 2,125,000 shares by certain selling stockholders of Lovesac, including 375,000 shares per the full exercise of the over-allotment option. The shares were sold at the public offering price of $36.00 per share. ROTH Capital Partners acted as joint book-running manager…

Continue Reading

TuesdayJun 04, 2019 12:56 pm

NetworkNewsBreaks – Nightfood Holdings Inc. (NGTF) Finalist in Multiple Categories for 2019 World Dairy Innovation Awards

Nightfood Holdings (OTCQB: NGTF), the innovative company solving America’s $50 billion nighttime snacking problem, today announced that it has been named a finalist in the 2019 World Dairy Innovation Awards. According to the update, Nightfood was entered in four categories and is a finalist in three categories for the awards, including: Best Dairy Dessert, Best Ice Cream and Best Brand. “This is amazing news for our brand,” Nightfood CEO Sean Folkson said in the news release. “Our goal is not necessarily to win awards, but winning, or being named a finalist, sends very clear signals to supermarket category managers about…

Continue Reading

TuesdayJun 04, 2019 12:45 pm

NetworkNewsBreaks – HempFusion Engages RADD Capital for Advisory Services Related to $30M Funding Initiative

Leading hemp-based CBD company HempFusion this morning announced its engagement of RADD Capital for advisory services related to its 2019 private funding initiative, which is valued in excess of $30 million. RADD Capital has a proven track record in the hemp and cannabis industries, having previously led private financings and initial public offerings for Organigram, Emblem Corp., The Green Organic Dutchman and PLUS Products. Additionally, RADD Capital led a separate $6 million investment into HempFusion earlier this year. Per the update, HempFusion launched its current funding initiative as part of its plan to diversify its product offerings, launch a revamped…

Continue Reading